Maximus (MMS) officer Ilene Baylinson reports dividend-equivalent RSU rights

Rhea-AI Filing Summary

Maximus, Inc. disclosed that officer Ilene Baylinson acquired additional common stock-related rights through dividend equivalents on restricted stock units. On 12/01/2025, she received 27.639 dividend equivalent rights, each economically equivalent to one share of Maximus common stock, at a price of $0 as part of her existing equity awards. Following this transaction, she beneficially owned 21,576.774 shares of common stock in direct ownership, reflecting accumulated equity compensation rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Baylinson Ilene R.

Role General Mgr - Health & Human

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	27.639	$0.00	--

Holdings After Transaction: Common Stock — 21,576.774 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baylinson Ilene R.

(Last) (First) (Middle)

C/O MAXIMUS INC.

1600 TYSONS BLVD, STE 1400

(Street)

MCLEAN VA 22102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MAXIMUS, INC. [ MMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Mgr - Health & Human

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		A		27.639(1)	A	$0	21,576.774	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of Maximus common stock.

	/s/ John T Martinez: As Attorney-In-Fact for: Ilene Baylinson	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Maximus (MMS) report for Ilene Baylinson?

Maximus reported that officer Ilene Baylinson acquired 27.639 dividend equivalent rights tied to previously awarded restricted stock units on 12/01/2025.

What are the dividend equivalent rights reported for Maximus (MMS)?

The filing states that dividend equivalent rights accrued on previously awarded RSUs and vest proportionately with those RSUs, with each right equal in economic value to one share of Maximus common stock.

Did Ilene Baylinson pay cash for the Maximus (MMS) shares reported?

No cash was paid in this transaction; the 27.639 dividend equivalent rights were acquired at a price of $0 as part of her equity compensation.

How many Maximus (MMS) shares does Ilene Baylinson beneficially own after this transaction?

After the reported transaction, Ilene Baylinson beneficially owned 21,576.774 shares of Maximus common stock in direct ownership.

What position does Ilene Baylinson hold at Maximus (MMS)?

Ilene Baylinson is reported as an officer of Maximus with the title General Manager - Health & Human.

Was this Maximus (MMS) Form 4 filed for one or multiple reporting persons?

The Form 4 was indicated as filed by one reporting person, covering the holdings and transaction of Ilene Baylinson only.